Goldman Sachs’s NextCure NXTC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-93,478
| Closed | -$138K | – | 5072 |
|
|
2023
Q1 | $138K | Sell |
93,478
-216,266
| -70% | -$320K | ﹤0.01% | 4617 |
|
|
2022
Q4 | $437K | Sell |
309,744
-26,594
| -8% | -$37.5K | ﹤0.01% | 4166 |
|
|
2022
Q3 | $925K | Sell |
336,338
-2,670
| -0.8% | -$7.34K | ﹤0.01% | 3877 |
|
|
2022
Q2 | $1.59M | Sell |
339,008
-34,078
| -9% | -$160K | ﹤0.01% | 3617 |
|
|
2022
Q1 | $1.81M | Buy |
373,086
+39,958
| +12% | +$194K | ﹤0.01% | 3658 |
|
|
2021
Q4 | $2M | Buy |
333,128
+233,266
| +234% | +$1.4M | ﹤0.01% | 3498 |
|
|
2021
Q3 | $673K | Sell |
99,862
-17,691
| -15% | -$119K | ﹤0.01% | 4219 |
|
|
2021
Q2 | $944K | Sell |
117,553
-97,447
| -45% | -$783K | ﹤0.01% | 4062 |
|
|
2021
Q1 | $2.15M | Sell |
215,000
-17,677
| -8% | -$177K | ﹤0.01% | 3304 |
|
|
2020
Q4 | $2.54M | Buy |
232,677
+95,782
| +70% | +$1.04M | ﹤0.01% | 2927 |
|
|
2020
Q3 | $1.21M | Buy |
136,895
+77,074
| +129% | +$678K | ﹤0.01% | 3205 |
|
|
2020
Q2 | $1.28M | Buy |
59,821
+509
| +0.9% | +$10.9K | ﹤0.01% | 3093 |
|
|
2020
Q1 | $2.2M | Buy |
59,312
+45,515
| +330% | +$1.69M | ﹤0.01% | 2707 |
|
|
2019
Q4 | $777K | Buy |
13,797
+6,741
| +96% | +$380K | ﹤0.01% | 3451 |
|
|
2019
Q3 | $218K | Buy |
+7,056
| New | +$218K | ﹤0.01% | 3888 |
|